6 min listen
Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer
FromASCO Education
Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer
FromASCO Education
ratings:
Length:
5 minutes
Released:
May 30, 2018
Format:
Podcast episode
Description
Dr. Linh Alejandro, a clinical oncology pharmacist at the University of California, San Diego Health Systems discusses the approval of olaparib for germline BRCA-mutated metastatic breast cancer.
Released:
May 30, 2018
Format:
Podcast episode
Titles in the series (100)
ASCO Guidelines: Secondary Prevention of Cervical Cancer: ASCO Guidelines: Secondary Prevention of Cervical Cancer by ASCO Education